Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-24 @ 7:48 PM
NCT ID:
NCT04092803
Eligibility Criteria:
Inclusion Criteria:
1. Pediatric and young adult patients 10-25 years of age
2. Lumbar puncture for chemotherapy per leukemia therapy
3. Cognitively appropriate
4. Assessed by child life specialist as appropriate to use VR
5. Previous LP with GA
6. Tested negative for COVID-19
Exclusion Criteria:
1. History of seizures
2. Active headache
3. Active nausea or vomiting
4. ASA (American Society of Anesthesiologists) greater than 4
5. Allergy to lidocaine, procaine, or propofol
6. Developmental delay
7. No previous LP with GA
8. Tested positive for COVID-19, or opted out of of COVID-19 testing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
25 Years
Study:
NCT04092803
Study Brief:
Protocol Section:
NCT04092803